Cardiff Oncology, Inc. - COM (CRDF)

Historical Portfolio Holders from Q2 2020 to Q1 2024

All holders as of March 31, 2024: Q1 2024
Type / Class: Equity / COM
Shares, excl. options Q1 2024: 8.34 M
Holdings value Q1 2024: $44.5 M
Value change Q1 2024: +$16.7 M
Grand Portfolio weight change Q1 2024: +0%
Number of holders: 73
Number of buys Q1 2024: 0
Number of sells Q1 2024: 0
Average buys Q1 2024 %: 0
Average sells Q1 2024 %: 0
CUSIP: 14147L108

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Period	Shares, Excl. Options	Value, Excl. Options	Change	Puts Notional Value	Calls Notional Value	Price	Investors
2024 Q1	8.34 M	$44.5 M	+$16.7 M	209 K	4.26 M	$5.34	74
2023 Q4	5.28 M	$7.81 M	-$215 K	43.1 K	27.2 K	$1.48	53
2023 Q3	5.46 M	$7.58 M	-$761 K	77.8 K	274 K	$1.39	57
2023 Q2	5.96 M	$8.76 M	-$1.4 M	0	14.8 K	$1.47	48
2023 Q1	7.04 M	$11.6 M	-$750 K	114 K	6.11 K	$1.65	51
2022 Q4	7.7 M	$10.8 M	-$169 K	69.4 K	3.5 K	$1.40	55
2022 Q3	7.92 M	$12.2 M	-$1.98 M	202 K	167 K	$1.54	48
2022 Q2	8.53 M	$18.8 M	-$14.1 M	226 K	399 K	$2.20	52
2022 Q1	14 M	$34.7 M	-$28.7 M	378 K	224 K	$2.48	79
2021 Q4	21.5 M	$129 M	+$2.51 M	1.16 M	748 K	$6.01	79
2021 Q3	21 M	$140 M	-$33.6 M	2.06 M	1.43 M	$6.66	82
2021 Q2	26.4 M	$175 M	+$10.6 M	1.84 M	1.13 M	$6.65	83
2021 Q1	24.1 M	$223 M	-$70 M	7.38 M	2.29 M	$9.26	71
2020 Q4	26.6 M	$479 M	+$144 M	13.4 M	7.47 M	$17.99	81
2020 Q3	18.7 M	$266 M	+$208 M	2.87 M	6.25 M	$14.19	65
2020 Q2	4.92 M	$24.7 M	+$24.7 M			$5.01	22